# Forensic Dossier: Study Forensics: Gene therapy elevating Klotho protein extends lifespan in mice

**Run ID:** `mechfix_study-forensics-024_Claude_Sonnet_572828`  
**Task:** study-forensics-024 | study_forensics | hard | study_forensics  
**Timestamp:** 2026-04-08T16:40:59.821865+00:00  
**Task Family:** mechanism_vs_evidence  
**Trap Type:** animal_to_human_overreach  
**Ambiguity:** low  

## Executive Summary

**Agents tested:** Claude Sonnet
**Winner:** Claude Sonnet — **70.1/100** (margin: 0.0)
**Failure modes:** decorative_self_check, missed_key_insight, unused_assumption
**Forensic flags:** 1
**Consistency findings:** 9
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Sonnet | 30.0/30 | 2.4/8 | 5.4/8 | 2.9/6 | 3.9/6 | 4.5/6 | 0.0/8 | 8.0/8 | 3.0/10 | 10.0/10 | **70.1/100** |

## Study Forensics Audit

### Claude Sonnet

**Classification:** `mechanism_vs_evidence` [+] (gold: `mechanism_vs_evidence`)
**Finding Recall:** 67%
**Matched Findings:** mechanism_not_demonstrated, conclusion_exceeds_results
**Missed Findings:** unsupported_generalization

## Reasoning Integrity Audit

### Claude Sonnet
**Classification:** Correct and well-supported
**Load-bearing steps:** 1 / 5

## Mechanism Analysis

### Claude Sonnet
| Aspect | Status |
|--------|--------|
| Concept named | :x: none |
| Mechanism described | :white_check_mark: (1 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** concept not named, mechanism not grounded to case data

## Grounding Audit

### Claude Sonnet
Conclusion claims: 1
- Direct support: 0
- Indirect support: 1
- Unsupported: 0
- Contradicted: 0


## Forensic Flags

### Claude Sonnet

- **[STYLISTIC]** `unnamed_mechanism`: Describes mechanism without naming the concept — under-explicit
  - `steps[4]`: "Classified as mechanism_vs_evidence due to leap from mouse studies to implied human applications"


## Evidence Map

### Claude Sonnet

**Correctness:** 30.0/30
  - (+) `final_answer`: "mechanism_vs_evidence"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 2.4/8
  - (+) `final_answer`: "mechanism_vs_evidence"
    _Conclusion grounded by reasoning chain_
  - Note: Support classification: 0 load-bearing, 1 supporting, 0 mentioned / 5
  - Note: Reasoning graph confirms conclusion grounding

**Structural Reasoning:** 5.4/8
  - (+) `steps[1]`: "Identified conclusion tier: text implies human therapeutic benefit through patent filing and 'healthier society' languag"
    _Most informative reasoning step_
  - Note: 5 reasoning steps
  - Note: Low step utility: 1/5 steps contribute

**Assumption Discipline:** 2.9/6
  - (+) `assumptions[2]`: "The patents and 'healthier society' language implies human therapeutic applications"
    _Most substantive assumption_
  - (-) `assumptions[0]`: "The study was conducted only in mice"
    _Declared but unused in reasoning_
  - (-) `assumptions[3]`: "The viral vector gene therapy approach described would need to translate to humans"
    _Declared but unused in reasoning_
  - Note: 4/4 substantive assumptions
  - Note: 2 unused assumption(s)

**Uncertainty Handling:** 3.9/6
  - (+) `uncertainties[1]`: "Degree to which 'healthier society' language constitutes therapeutic implication"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.88"
    _Stated confidence level_
  - Note: 3 uncertainties (3 substantive)
  - Note: Confidence 0.88

**Alternative Hypothesis Quality:** 4.5/6
  - (+) `alternative_hypotheses[1]`: "Could be 'overclaim' if focusing on the strength of therapeutic promises"
    _Most substantive alternative hypothesis_
  - Note: 2 alternative hypotheses considered
  - Note: 2/2 genuinely diverse alternatives

**Self Monitoring Quality:** 0.0/8
  - (+) `self_check[2]`: "Checked that hedging language doesn't resolve the tier mismatch"
    _Most substantive self-verification step_
  - (-) `self_check[0]`: "Confirmed this is animal-to-human bridge"
    _Fluff self-check_
  - Note: 4 self-check items
  - Note: Self-check quality: 0 deep, 0 arithmetic, 4 fluff

**Mechanism Quality:** 3.0/10
  - (+) `(mechanism analysis)`: "Classified as mechanism_vs_evidence due to leap from mouse studies to implied human applications"
    _Mechanism description_
  - Note: Describes mechanism but does not name concept

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.80, 197 words

**Insight Depth:** 8.0/8
  - Note: Key insights: 2 full / 2


## Failure Analysis

### Claude Sonnet

**MODERATE:**
- **Missed Key Insight** `[MEDIUM CONFIDENCE]`: Missed expected finding: unsupported_generalization
  - `(task expectation)`: "Expected: unsupported_generalization"
  - _Impacts: insight_depth_

**MINOR:**
- **Decorative Self Check** `[HEURISTIC]`: All 4 self-checks appear to be fluff — no substantive verification
  - `self_check[0]`: "Confirmed this is animal-to-human bridge"
  - _Impacts: self_monitoring_quality_

**STYLISTIC:**
- **Unused Assumption** `[HEURISTIC]`: Assumption 'The study was conducted only in mice...' is declared but not referenced in reasoning
  - `assumptions[0]`: "The study was conducted only in mice"
  - _Impacts: assumption_discipline_
- **Unused Assumption** `[HEURISTIC]`: Assumption 'The viral vector gene therapy approach described would need ...' is declared but not referenced in reasoning
  - `assumptions[3]`: "The viral vector gene therapy approach described would need to translate to humans"
  - _Impacts: assumption_discipline_


## Consistency & Grounding Audit

### Claude Sonnet

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/4 content words)
  - `key_claims[0]`: "Mouse longevity increased 15-20%"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/5 content words)
  - `key_claims[1]`: "Multiple health parameters improved in mice"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/5 content words)
  - `key_claims[2]`: "Patents filed for treating human conditions"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 4 has low overlap with final answer (0/7 content words)
  - `key_claims[3]`: "Gene therapy 'could help build healthier society'"
- **[WARN]** `[HEURISTIC]` `unused_assumption`: Assumption 1 appears unused in reasoning or answer
  - `assumptions[0]`: "The study was conducted only in mice"
- **[WARN]** `[HEURISTIC]` `unused_assumption`: Assumption 4 appears unused in reasoning or answer
  - `assumptions[3]`: "The viral vector gene therapy approach described would need to translate to humans"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 1 is stated without rejection reasoning
  - `alternative_hypotheses[0]`: "Could be 'solid' if interpreted as purely describing mouse research"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 2 is stated without rejection reasoning
  - `alternative_hypotheses[1]`: "Could be 'overclaim' if focusing on the strength of therapeutic promises"
- **[NOTE]** `[MEDIUM CONFIDENCE]` `mechanism_gap`: Causal mechanism described but underlying concept not named
  - `final_answer`: "mechanism_vs_evidence"


## Agent Profiles

### Claude Sonnet (claude-sonnet-4-20250514)
**Parse OK:** True | **Latency:** 10284ms

**Final Answer:** mechanism_vs_evidence

**Confidence:** 0.88

**Assumptions:**
- The study was conducted only in mice
- No human clinical trials are mentioned
- The patents and 'healthier society' language implies human therapeutic applications
- The viral vector gene therapy approach described would need to translate to humans

**Reasoning Steps:**
1. Identified evidence tier: animal studies in middle-aged mice
2. Identified conclusion tier: text implies human therapeutic benefit through patent filing and 'healthier society' language
3. Checked for bridge evidence: no human studies or clinical data mentioned
4. Evaluated hedging: while some cautious language exists ('could help'), the overall framing suggests human therapeutic potential
5. Classified as mechanism_vs_evidence due to leap from mouse studies to implied human applications

**Key Claims:**
- Mouse longevity increased 15-20%
- Multiple health parameters improved in mice
- Patents filed for treating human conditions
- Gene therapy 'could help build healthier society'

**Alternative Hypotheses:**
- Could be 'solid' if interpreted as purely describing mouse research
- Could be 'overclaim' if focusing on the strength of therapeutic promises

**Uncertainties:**
- Exact wording of patent claims not provided
- Degree to which 'healthier society' language constitutes therapeutic implication
- Whether additional human studies exist but weren't mentioned

**Self-Verification:**
- Confirmed this is animal-to-human bridge
- Verified no human clinical evidence mentioned
- Checked that hedging language doesn't resolve the tier mismatch
- Ensured I'm not overflagging a legitimate mouse study report

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 2.4/8 `###.......`
- Structural Reasoning: 5.4/8 `######....`
- Assumption Discipline: 2.9/6 `####......`
- Uncertainty Handling: 3.9/6 `######....`
- Alternative Hypothesis Quality: 4.5/6 `#######...`
- Self Monitoring Quality: 0.0/8 `..........`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 3.0/10 `###.......`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Sonnet** scored **70.1/100**.

**Best per dimension:**
- Correctness: Claude Sonnet (30.0/30)
- Support Strength: Claude Sonnet (2.4/8)
- Structural Reasoning: Claude Sonnet (5.4/8)
- Assumption Discipline: Claude Sonnet (2.9/6)
- Uncertainty Handling: Claude Sonnet (3.9/6)
- Alternative Hypothesis Quality: Claude Sonnet (4.5/6)
- Self Monitoring Quality: Claude Sonnet (0.0/8)
- Insight Depth: Claude Sonnet (8.0/8)
- Mechanism Quality: Claude Sonnet (3.0/10)
- Communication Efficiency: Claude Sonnet (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Sonnet | 10.3s | 70.1/100 | 6.8 |

Failure modes observed: decorative_self_check, missed_key_insight, unused_assumption.
